Dr. Reddy's Laboratories Limited
RDY
$12.22
$0.110.91%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 854.26M | 794.72M | 979.63M | 1.01B | 998.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 854.26M | 794.72M | 979.63M | 1.01B | 998.56M |
| Cost of Revenue | 456.90M | 438.49M | 454.21M | 457.15M | 430.32M |
| Gross Profit | 397.36M | 356.23M | 525.42M | 551.41M | 568.24M |
| SG&A Expenses | 305.06M | 293.54M | 302.17M | 302.81M | 299.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.05M | -7.33M | -6.63M | -8.48M | -9.10M |
| Total Operating Expenses | 817.94M | 782.47M | 818.77M | 822.52M | 793.89M |
| Operating Income | 36.32M | 12.25M | 160.86M | 186.04M | 204.67M |
| Income Before Tax | 58.49M | 21.05M | 173.20M | 210.19M | 222.58M |
| Income Tax Expenses | 12.47M | -2.26M | 39.66M | 46.74M | 57.86M |
| Earnings from Continuing Operations | 46.02M | 23.31M | 133.54M | 163.44M | 164.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 920.90K | -42.30K | 2.27M | 1.19M | 958.20K |
| Net Income | 46.94M | 23.27M | 135.81M | 164.63M | 165.68M |
| EBIT | 36.32M | 12.25M | 160.86M | 186.04M | 204.67M |
| EBITDA | 93.18M | 53.22M | 219.38M | 243.90M | 260.36M |
| EPS Basic | 0.06 | 0.03 | 0.16 | 0.20 | 0.20 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.13 | 0.15 | 0.16 |
| EPS Diluted | 0.06 | 0.03 | 0.16 | 0.20 | 0.20 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.13 | 0.15 | 0.16 |
| Average Basic Shares Outstanding | 833.65M | 833.71M | 832.62M | 832.68M | 832.04M |
| Average Diluted Shares Outstanding | 833.65M | 833.71M | 833.20M | 833.16M | 833.02M |
| Dividend Per Share | -- | 0.08 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 46.33% | -- |